Dr Choueiri on the Clinical Significance of Adjuvant Belzutifan Plus Pembrolizumab in ccRCC | OncLive
onclive.com
Dr Choueiri on the Clinical Significance of Adjuvant Belzutifan Plus Pembrolizumab in ccRCC | OncLive
Toni K. Choueiri, MD, discusses the potential clinical effects of data from the phase 3 LITESPARK-022 study.
6 days ago
Related Products
Adjuvant Pembrolizumab RCC
Adjuvant Analgesics
Adjuvant Background
#Pembrolizumab Uses
Pembrolizumab: Monotherapy Versus Combination Therapy | OncLive
Pembrolizumab: Monotherapy Versus Combination Therapy | OncLive
onclive.comJun 28, 2018
Just Published: Adjuvant pembrolizumab after resected stage III melanoma led to a 5-year recurrence-free survival of 55.4%, compared with 38.3% in patients treated with placebo. Read more in NEJM Evidence: https://eviden.cc/3x6Wg6l #ESMO22 | The New England Journal of Medicine
Just Published: Adjuvant pembrolizumab after resected stage III melanoma led to a 5-year recurrence-free survival of 55.4%, compared with 38.3% in patients treated with placebo. Read more in NEJM Evidence: https://eviden.cc/3x6Wg6l #ESMO22 | The New England Journal of Medicine
FacebookSep 10, 2022
Top videos
Phase II #NESCIO trial of neoadjuvant immunotherapy in #RenalCellCarcinoma. Femke Burgers, MD, PhD Antoni van Leeuwenhoek joins Pedro Barata, MD, MSc, FACP Case Comprehensive Cancer Center to discuss the NESCIO trial, an investigator-initiated phase II study evaluating neoadjuvant immunotherapy in patients with intermediate to high-risk clear cell #RCC. #WatchNow > bit.ly/3OdRDTh | UroToday
2:01
Phase II #NESCIO trial of neoadjuvant immunotherapy in #RenalCellCarcinoma. Femke Burgers, MD, PhD Antoni van Leeuwenhoek joins Pedro Barata, MD, MSc, FACP Case Comprehensive Cancer Center to discuss the NESCIO trial, an investigator-initiated phase II study evaluating neoadjuvant immunotherapy in patients with intermediate to high-risk clear cell #RCC. #WatchNow > bit.ly/3OdRDTh | UroToday
FacebookUroToday
24 views1 month ago
Recent Data in the Adjuvant Setting of RCC | OncLive
Recent Data in the Adjuvant Setting of RCC | OncLive
onclive.com
Sep 8, 2017
Neoadjuvant and Perioperative Management of RCC: Key Challenges and Opportunities
Neoadjuvant and Perioperative Management of RCC: Key Challenges and Opportunities
vumedi.com
4 months ago
Pembrolizumab Side Effects
Dr. Machiels on Toxicities with Pembrolizumab for Head and Neck Cancer | OncLive
Dr. Machiels on Toxicities with Pembrolizumab for Head and Neck Cancer | OncLive
onclive.com
Jun 20, 2017
Effets secondaires de Keytruda (pembrolizumab), interactions, utilisations et empreinte thérapeutique - Santé 2026
Effets secondaires de Keytruda (pembrolizumab), interactions, utilisations et empreinte thérapeutique - Santé 2026
oldmedic.com
Sep 2, 2019
Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer | OncLive
Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer | OncLive
onclive.com
Dec 22, 2022
Phase II #NESCIO trial of neoadjuvant immunotherapy in #RenalCellCarcinoma. Femke Burgers, MD, PhD Antoni van Leeuwenhoek joins Pedro Barata, MD, MSc, FACP Case Comprehensive Cancer Center to discuss the NESCIO trial, an investigator-initiated phase II study evaluating neoadjuvant immunotherapy in patients with intermediate to high-risk clear cell #RCC. #WatchNow > bit.ly/3OdRDTh | UroToday
2:01
Phase II #NESCIO trial of neoadjuvant immunotherapy in #R…
24 views1 month ago
FacebookUroToday
Recent Data in the Adjuvant Setting of RCC | OncLive
Recent Data in the Adjuvant Setting of RCC | OncLive
Sep 8, 2017
onclive.com
Neoadjuvant and Perioperative Management of RCC: Key Challenges and Opportunities
Neoadjuvant and Perioperative Management of RCC: Key Challen…
4 months ago
vumedi.com
Dr. McGregor on Advances Made in the Adjuvant Setting of RCC | OncLive
Dr. McGregor on Advances Made in the Adjuvant Setting of RCC | Onc…
Jun 8, 2019
onclive.com
Prognostic Factors and Treatment Selection in RCC | OncLive
Prognostic Factors and Treatment Selection in RCC | OncLive
Jun 25, 2014
onclive.com
Dr Haas on the Rationale for Evaluating Adjuvant Pembrolizumab in Clear Cell RCC | OncLive
1:30
Dr Haas on the Rationale for Evaluating Adjuvant Pembrolizum…
6 months ago
onclive.com
ASCO® GU 2025 Summary: Adjuvant Therapy in RCC - A Practical Guide
ASCO® GU 2025 Summary: Adjuvant Therapy in RCC - A Pract…
120 viewsFeb 24, 2025
vumedi.com
Dr. Nanus Discusses Adjuvant Therapy for RCC | OncLive
Mar 27, 2018
onclive.com
Adjuvant Sunitinib's Role in the Treatment of RCC | OncLive
Mar 8, 2018
onclive.com
RCC Management in 2025 and Beyond: Adjuvant Immunotherapy…
91 views11 months ago
vumedi.com
Risk-Adapted Treatment Selection After Nephrectomy: Adjuvant Imm…
24 views11 months ago
vumedi.com
Dr. Zhang on the Importance of Adjuvant Clinical Trials in RCC | O…
Jan 3, 2018
onclive.com
Dr. Voss Discusses Neoadjuvant Trials of Immunotherapy in RCC
Dec 1, 2017
onclive.com
Dr. George on the Use of Adjuvant Sunitinib in RCC | OncLive
Dec 1, 2018
onclive.com
Adjuvants bétons | Chryso Global
5 months ago
chryso.com
Dr. Uzzo on Potential of Adjuvant Therapy in Patients With RCC | On…
Nov 8, 2016
onclive.com
Dr. Nanus on Ongoing Studies in the Neoadjuvant Setting for RCC | On…
May 3, 2017
onclive.com
Dr Pal on Future Research Directions With Adjuvant Immunot…
7 months ago
onclive.com
Adjuvant and Combination Therapies for HCC | OncLive
May 28, 2015
onclive.com
HCC: The Criteria for Adjuvant Therapy | OncLive
1 month ago
onclive.com
Potential Immunotherapy Combinations in RCC | OncLive
Jul 18, 2014
onclive.com
2:30
Adjuvant Pembrolizumab Delivers Long-Term Benefits in ccRCC at I…
3 months ago
onclive.com
RCC: Resection in Metastatic Disease
Sep 8, 2017
onclive.com
Key Takeaway 2: Frontline Neoadjuvant Chemotherapy | Onc…
Sep 16, 2019
onclive.com
Managing Disease Progression in RCC | OncLive
Jan 29, 2016
onclive.com
Advanced RCC Treatment Options Post-Progression | OncLive
Mar 31, 2023
onclive.com
PD-1 Combinations Explored in RCC | OncLive
Jul 18, 2014
onclive.com
Switching Therapies for Progressive Advanced RCC | OncLive
Jul 21, 2015
onclive.com
Checkpoint Inhibitors Under Exploration in RCC | OncLive
Jul 18, 2014
onclive.com
See more videos
Static thumbnail place holder